Thalidomide Survivors Contribution Program Class Proceeding – January 13, 2021
January 13, 2021
The class members seeking leave to appeal the settlement approval decision were denied leave by the Federal Court of Appeal in November 2020. A copy of the Federal Court of Appeal’s decision can be found here: http://canlii.ca/t/jbdk7.
However, one class member has now filed a further application for leave to appeal this dismissal to the Supreme Court of Canada. This means that implementation of the Settlement approved in May 2020 remains on hold for all class members.
We will provide a further update as this leave to appeal process progresses.